Drug intelligence / Profile preview

grass pollen + olive tree pollen vaccine

Development stage
Unknown
Lead developer
Inmunotek
Modality
Vaccines & Immunotherapeutics
Administration
Sublingual, Subcutaneous
01

Overview

The grass pollen + olive tree pollen vaccine is an allergen immunotherapy (AIT) developed by Inmunotek S.L., specifically formulated for the treatment of allergic rhinitis, allergic rhinoconjunctivitis, and controlled allergic asthma. This vaccine utilizes polymerized allergen extracts, known as allergoids, which are created by treating natural pollen extracts from various grasses (typically a 5-grass mix including *Phleum pratense*) and olive tree (*Olea europaea*) with glutaraldehyde. This chemical modification reduces the allergen's IgE-binding capacity, thereby minimizing the risk of systemic allergic reactions during administration, while preserving the T-cell epitopes necessary for inducing immune tolerance. The vaccine works by promoting a shift from a Th2-dominated immune response to a Th1 and regulatory T-cell (Treg) response, leading to the production of blocking antibodies like IgG4 and the secretion of anti-inflammatory cytokines such as IL-10. It is available in different delivery formats, including the sublingual spray Oraltek and the subcutaneous depot injection Alunitek.

Brand names
OraltekAlunitek
Other names
Polymerized grass and olive pollen extractGrass/Olive AllergoidPolymerized Extract of Grasses and Olive Pollen
02

Targets

IL10 (Interleukin-10)IgE (Immunoglobulin E)

Beyond the preview

Go deeper on grass pollen + olive tree pollen vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on grass pollen + olive tree pollen vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call